AngioDynamics, Inc.
ANGO
$13.59
$0.151.12%
NASDAQ
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.05% | 8.91% | 9.04% | 12.18% | 12.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.05% | 8.91% | 9.04% | 12.18% | 12.93% |
| Cost of Revenue | 4.99% | 11.46% | 5.19% | 10.03% | 16.86% |
| Gross Profit | 10.79% | 6.75% | 12.22% | 13.98% | 9.61% |
| SG&A Expenses | 12.98% | 6.17% | 2.58% | 11.14% | 4.83% |
| Depreciation & Amortization | 5.02% | 2.69% | 3.16% | 3.23% | 0.54% |
| Other Operating Expenses | 127.99% | -- | -- | -- | -536.28% |
| Total Operating Expenses | 10.76% | 7.88% | 5.14% | 9.72% | 8.32% |
| Operating Income | -79.94% | 3.29% | 50.89% | 9.33% | 46.94% |
| Income Before Tax | -80.61% | -83.08% | 41.42% | 14.43% | 56.79% |
| Income Tax Expenses | 716.67% | 700.00% | 95.45% | -51.13% | 91.33% |
| Earnings from Continuing Operations | -88.51% | -83.44% | 40.86% | 14.81% | 55.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.51% | -83.44% | 40.86% | 14.81% | 55.02% |
| EBIT | -79.94% | 3.29% | 50.89% | 9.33% | 46.94% |
| EBITDA | 50.07% | -154.71% | 81.65% | 2.49% | 52.90% |
| EPS Basic | -85.30% | -80.07% | 41.73% | 15.88% | 55.64% |
| Normalized Basic EPS | -84.28% | -40.36% | 44.50% | 3.61% | 39.10% |
| EPS Diluted | -81.97% | -76.64% | 41.73% | 15.88% | 55.36% |
| Normalized Diluted EPS | -84.28% | -40.36% | 44.50% | 3.61% | 39.10% |
| Average Basic Shares Outstanding | 1.74% | 1.82% | 1.52% | 1.28% | 1.38% |
| Average Diluted Shares Outstanding | 1.74% | 1.82% | 1.52% | 1.28% | 1.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |